Chairs: Roberta Rudà (Italy), Filip De Vos (Netherlands), Peter Hau (Germany)

Note that the programme is subject to change and will be continuously updated.
All times below refer to Central European Time (CET).

10:00 - 10:45
M5.01 Molecular pathology of ependymomas and medulloblastomas
Felix Sahm, Germany

11:00 - 11:45
M5.02 Surgical therapy in ependymomas and medulloblastomas
Luca Regli, Switzerland

12:00 - 12:45
M5.03 Multimodal therapies for ependymomas and medulloblastomas
Peter Hau, Germany

12:45 - 13:45
Lunch Break

13:45 - 14:30
M5.04 Neuroimaging of rare brain tumors
tbc

14:45 - 15:30
M5.05 When and how radiotherapy has indication?
Frederic Dhermain, France

10:00 - 10:45
M5.06 Molecular pathology of rare circumscribed gliomas and glioneuronal tumors
tbc

11:00 - 11:45
M5.07 Surgical therapy for rare circumscribed gliomas and glioneuronal tumors: oncological and epileptological value
Johan Pallud, France

12:00 - 12:45
M5.08 Multimodal therapies for rare circumscribed gliomas and glioneuronal tumors: case discussion
Roberta Rudà, Italy

12:45 - 13:45
Lunch Break

13:45 - 14:30
M5.09 Pineal and very rare tumors
Evangelia Razis, Greece

14:45 - 15:30
M5.10 New trial design and concepts for rare tumor
Mark Gilbert, United States

15:30 - 16:30
Test

The European Association of Neuro-Oncology (EANO) will be seeking accreditation from the European Accreditation Council of Continuing Medical Education.